Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study Assessing the Effects of Ranolazine on Coronary Microvascular Dysfunction in Patients With Hypertrophic Cardiomyopathy

NCT03953989 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT03953989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03953989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study Assessing the Effects of Ranolazine on Coronary Microvascular Dysfunction in Patients With Hypertrophic Cardiomyopathy
Lead sponsor
IRCCS San Raffaele
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2016
Completion date
March 6, 2020
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hcm - hypertrophic non-obstructive cardiomyopathy